Seminars in Diagnostic Pathology
Volume 25, Issue 4 , Pages 288-294 , November 2008

KRAS mutational testing in the selection of patients for EGFR-targeted therapies

  • Joaquin Garcia

      Affiliations

    • Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Gregory J. Riely

      Affiliations

    • Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Khedoudja Nafa

      Affiliations

    • Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Marc Ladanyi, MD

      Affiliations

    • Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York
    • Human Oncology & Pathogenesis Program, Memorial Sloan–Kettering Cancer Center, New York, New York
    • Corresponding Author InformationAddress reprint requests and correspondence: Marc Ladanyi, MD, Department of Pathology, Memorial Sloan–Kettering Cancer Center, Room S-801, 1275 York Avenue, New York, NY 10065

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0740-2570(08)00067-1

doi: 10.1053/j.semdp.2008.08.003

Seminars in Diagnostic Pathology
Volume 25, Issue 4 , Pages 288-294 , November 2008

Article Tools

* Image Usage & Resolution